Research Grade Anti-MERS-CoV RBD Antibody (REGN3051) (VK800016)

Datasheet Share product Copy info

Price(USD): $

Spec:

100ug
1mg

Number:

Overview
Images
References
Datasheet

Overview

Catalog No.	VK800016
Description	Anti-MERS-CoV RBD Antibody (REGN3051) (VK800016) is a research-grade recombinant antibody targeting RBD. Produced in mammalian cells with native-like glycosylation. Highlights ●Research Grade — For PK/PD studies, assay development, and ADA research. ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Species reactivity	Middle East respiratory syndrome-related coronavirus (isolate UnitedKingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1)
Applications	ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Host species	Human
Isotype	IgG1
Clone ID	REGN3051
Expression system	Mammalian Cells
Clonality	Monoclonal
Target	RBD
Endotoxin level	Please contact the lab for this information.
Purity	>95% purity as determined by SDS-PAGE.
Purification	Protein A/G purified from cell culture supernatant.
Accession	K9N5Q8
Form	Liquid
Storage buffer	0.01M PBS, pH 7.4. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
Stability and Storage	Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names	Ab2, H1H15211P, REGN-3051
Background	Spike glycoprotein (RBD) is a ~149 kDa protein. Attaches the virion to the cell membrane by interacting with host receptor, initiating the infection. Interacts with host DPP4 to mediate virla entry.
Note	For research use only. Not suitable for clinical or therapeutic use.